|
|
| Nomenclature |
|
Symbol:
|
Tg(Tyr-cre/ERT2)1Laru
|
|
Name:
|
transgene insertion 1, Lionel Larue
|
|
MGI ID: |
MGI:3617509 |
|
Synonyms: |
Tyr::Cre-ERT2 |
|
Transgene:
|
Tg(Tyr-cre/ERT2)1Laru
Location:
unknown
|
|
Transgene
origin |
|
Strain of Origin:
|
C57BL/6 x DBA/2
|
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (Cre/Flp) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: This transgene expresses a tamoxifen inducible form of cre recombinase under control of the tyronsinase enhancer and promoter, active in melanoblasts and melanocytes. (J:105276)
|
|
|
Recombinase activity
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available |
|
|
Notes |
Phenotypic Similarity to Human Syndrome: Melanoma (tamoxifen-treated Braftm1Cpri/ Braftm1Cpri Tg(Tyr-cre/ERT2)1Laru mice J:147434)
|
| References |
|
Original: |
J:105276
Yajima I et al.,
"Spatiotemporal gene control by the Cre-ERT2 system in melanocytes."
Genesis 2006 Jan;44(1):34-43
|
|
All: |
6 reference(s)
|
|
Analysis Tools
